Beta-3 adrenergic receptor agonist

This page covers all Beta-3 adrenergic receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-3 adrenergic receptor (ADRB3), beta-3 adrenergic receptor.

Targets

Beta-3 adrenergic receptor (ADRB3) · beta-3 adrenergic receptor

Marketed (3)

• daytime dosing of mirabegron · Far Eastern Memorial Hospital · Urology
  Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity.
• Mirabegron tablet · Astellas Pharma Inc · Urology
  Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity.
• nighttime dosing of mirabegron · Far Eastern Memorial Hospital · Urology
  Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity.

Phase 3 pipeline (2)

• Placebo to Mirabegron · Astellas Pharma Inc · Urology
  Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity.
• amibegron (SR58611A) · Sanofi · Urology
  Amibegron is a beta-3 adrenergic receptor agonist.

Patent intelligence

• beta 3 adrenergic receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates